Sanum Pharma is dedicated to supporting licensed medical professionals who prescribe or dispense cannabinoid based medicines. Our African roots are central to our approach, connecting trusted cultivation and manufacturing expertise with the high standards of the European pharmaceutical market.
Our focus on controlled substances means every aspect of our service is built around quality, compliance and reliability. We meet all applicable regulatory requirements in accordance with EU GMP guidelines, with rigorous quality controls, documentation, traceability and testing throughout our supply chain.
Through established partnerships and a controlled distribution network, we provide healthcare professionals with dependable access to pharmaceutical cannabinoid products, backed by the quality assurance and regulatory standards expected within the European healthcare environment.
Healthcare professionals submit their credentials for verification. This ensures compliance with controlled-substance distribution requirements and maintains the integrity of our partner network.
Once approved, practitioners receive access to a secure portal that contains detailed cannabinoid product information, specifications and ordering functionality. This area is reserved exclusively for authorised partners.
Orders are placed directly through the portal. Our distribution team manages the process from fulfilment through delivery, ensuring careful handling, accurate documentation and timely arrival at your practice or pharmacy.
We offer reliable communication, order tracking and a responsive support team to assist with documentation, supply planning and any clinical information required for dispensing.

Sanum Pharma distributes pharmaceutical cannabinoid formulations intended for use within approved therapeutic areas.
While full product details are only available within the secure portal, our portfolio includes controlled formulations suitable for medical prescribing and pharmacy dispensing.
All products meet strict standards for cannabinoid profile accuracy, potency consistency and contaminant testing.

Our collaboration with specialised manufacturing partners enables us to support a range of formulation needs.
Whether your practice requires consistent volumes or occasional small-batch requests, we work to ensure continuity and supply stability.
Flexibility is built into our distribution model to meet the diverse needs of clinical environments.

We provide reliable distribution across Germany and broader European markets.
Shipments are handled with controlled-substance protocols, ensuring that every order is delivered with full documentation, secure packaging and predictable timelines.
Our infrastructure is designed to support uninterrupted access to cannabinoid-based medicines.
Every product we distribute is subject to structured quality control procedures. This includes analytical testing, cannabinoid profiling, stability checks and comprehensive traceability from cultivation to final dispatch. Documentation accompanies each batch to support clinical and regulatory requirements.
Sanum Pharma upholds all relevant European regulatory standards governing the distribution of cannabinoid medicines. Our processes align with GDP guidelines, controlled-substance handling regulations and mandatory record-keeping policies. These measures ensure a compliant and auditable distribution pathway for every product.
We take our responsibility to patient safety seriously. Our pharmacovigilance framework allows practitioners to report product concerns or adverse events, enabling clear communication and swift action. Traceability systems ensure that every batch can be accurately tracked through the supply chain, supporting transparency and safety throughout clinical use.